Professor Peter Jones
Head of Department
Professor Peter Jones is pleased to consider applications from prospective PhD students.
The Cambridge “epiCentre” group works at the interface between population-based research, neuroscience and clinical psychiatry in order to understand the causes, mechanisms and treatments for psychosis (particularly schizophrenia) dementia, depression and bipolar disorder.
We investigate classical epidemiological characteristics in order to uncover causes, and have particular interests in cognition, longitudinal data and novel modelling approaches to defining life course descriptions of disorders and psychological dimensions in the population that we believe are stronger phenotypes for aetiological, genetic and treatment research than traditional approaches.
We have many local and international collaborators, particularly with the University of Oulu, Finland, and the MRC LHA unit. We have a strong partnership with the local clinical service for first episode psychosis, CAMEO (www.cameo.nhs.uk).
Current post-docs: James Kirkbride, Geof Hammond, Kate Xu, Jan Stochl, Linda Scoriels.
Randomised control trials
Matti Isohanni Web: http://cc.oulu.fi/~maisoh...
Barnett JH, Heron J, Jones PB (2007), “Gender-Specific Effects of the Catechol-O-Methyltransferase Val108/158Met Polymorphism on Cognitive Function in Children” Am J Psychiatry 164:142-149 Details
Jones PB, Barnes TR, Davies L, Dunn G, Lloyd H, Hayhurst KP, Murray RM, Markwick A, Lewis SW (2006), “Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia. Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)” Arch Gen Psychiatry 63:1079-1087 Details
Kirkbride J, Fearon P, Jones PB (2006), “Heterogeneity in Incidence Rates of Schizophrenia and Other Psychotic Syndromes. Findings From the 3-Center ÆSOP Study” Arch Gen Psychiatry 63:250-258 Details